about
High-resolution, noninvasive longitudinal live imaging of immune responsesDelivery of Bcl-XL or its BH4 domain by protein transduction inhibits apoptosis in human islets.Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct.Transdisciplinary approach to restore pancreatic islet function.Characterization of pancreatic ductal cells in human islet preparations.Prolactin supplementation to culture medium improves beta-cell survival.Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.Device design and materials optimization of conformal coating for islets of Langerhans.Noninvasive in vivo model demonstrating the effects of autonomic innervation on pancreatic islet function.Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations.Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy.MicroRNAs in islet immunobiology and transplantation.Influence of in vitro and in vivo oxygen modulation on β cell differentiation from human embryonic stem cells.Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells.HO-1 upregulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis.Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets.Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment.Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1.Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation.Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets.Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.Effects of pancreas cold ischemia on islet function and quality.Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes.c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice.Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice.Rapamycin impairs beta-cell proliferation in vivo.Rapamycin impairs in vivo proliferation of islet beta-cells.A functional CD40 receptor is expressed in pancreatic beta cells.Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosisProlonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodiesEarly assessment of apoptosis in isolated islets of LangerhansAbsence of M-CSF-dependent tissue macrophages does not improve delayed function of islet of Langerhans graftsDifferential engraftment of human peripheral blood lymphocytes in various strains of immunodeficient miceProlonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation
P50
Q30503251-C3B04E28-5287-46A9-873D-47F1DDF1AB88Q31112565-88B15024-A919-4364-AF1F-BF8E45D45ED9Q33186729-D3FB258E-D5D3-403E-937B-932C97BC58DEQ33220618-DE1C322A-8A0C-4B42-8E9A-3A92358F7E62Q33357060-E6CE41AB-E2CE-45A0-896D-2E199D77EA78Q33367926-248E523A-DAF6-4827-B540-C556D10EEF52Q33548278-B9D45595-16DE-4FE9-8687-11CEE9037571Q33750748-79BFE63C-8D7B-478F-8A21-B64C7CDFEDDFQ33971789-36A1E5FC-4CDC-410F-89B4-7590772E2EA9Q36504204-EC83954B-4F07-406A-9CCA-EF4C6DDA1133Q36601735-60413AD9-8420-4108-B81B-0D52E7FFEF86Q36796093-CB994AC0-8011-454B-8A12-3B7C8E6C9A3CQ37183811-6BC6477C-7ED0-4C4A-8BA7-2A500100EAFDQ37510124-2C22703E-4B6E-4964-BCE5-CA1C6F76E243Q38163421-C8F9F3D4-AAF9-479F-9B16-384BA84CAEACQ38266442-38545B82-FCFA-432F-AE97-A6556274AC9FQ40644955-A0CCBD96-AD97-4B7C-8A88-E2F265E73CABQ40818604-408AEEAE-BC06-4A23-B60B-E23CCC819CF6Q41914524-98FD96F2-0A03-406B-80A2-40E9579F2528Q43816653-2248B1B4-AD5E-4BE0-B6D8-F309CD076676Q44102776-7685208F-3158-4FDC-A023-CCF1199A944AQ44221095-5C0AEC18-63D9-4F65-A4E4-EB48D12F3E09Q44481002-F511BBA7-E7D4-4966-8649-398196ECE961Q44701643-04CF2B50-4ED0-47BD-8C24-E040B0D8B7EEQ44728965-F0A82A00-5985-4EDD-8C62-313DEB082B87Q45728988-6DCECCBF-37B2-4045-90CC-245B56C630C7Q45958462-0EFE2BAB-3F2D-4913-82DA-750AC906DFDAQ46275218-4664B0B3-81EC-4A32-97F1-ADBEA455AD84Q46318245-F53CFA54-3C80-40CA-A6C1-97C44DC9D720Q46401098-8ABC86EA-4A77-4169-AFC7-A097C2EC846BQ46670454-5410B6FB-2390-47C7-AB59-AE7AB60F5C67Q46676115-ACF7E436-679F-4555-8ED8-BAA7BE8BCDBFQ46828195-CC05DC6E-F6E6-4545-BD46-70001DFABC82Q54682415-B29796F3-1FF5-4470-A7BB-5EA28709D92BQ73519558-1CDACD72-1154-46FE-A082-49AFBB9CD67DQ73667529-A1AEC704-3F90-4574-8A26-66B768244532Q73667559-16E02890-2794-41DC-87A5-95E25DBB6C15Q73667722-11EFFFED-EBC4-4AAB-A47D-C4F7017674D3Q73668393-FB619350-7B28-41E4-AD35-BB79F1300165Q73679954-19CE900B-224F-47FE-9C7F-6B6C39173907
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-6132-8750
@en
name
Ruth D Molano
@ast
Ruth D Molano
@en
Ruth D Molano
@es
Ruth D Molano
@nl
type
label
Ruth D Molano
@ast
Ruth D Molano
@en
Ruth D Molano
@es
Ruth D Molano
@nl
prefLabel
Ruth D Molano
@ast
Ruth D Molano
@en
Ruth D Molano
@es
Ruth D Molano
@nl
P106
P1153
35408275000
P21
P31
P496
0000-0002-6132-8750